-
Dr. Zheng Lou: Integrating Traditional and Western Medicine to Overcome the Challenge of Anastomotic Leakage After Low Rectal Cancer Surgery| Annual Meeting of the Chinese Medical Doctor Association’s Colorectal Oncology Committee
With changing dietary habits and the increasing adoption of colorectal cancer screening, the incidence of low rectal cancer is on the rise in China. In Shanghai alone, the annual growth rate is estimated at 4.2% to 4.6%, with 70% to 80% of rectal cancers classified as mid-to-low rectal tumors. Despite advancements in surgical techniques, anastomotic…
-
SGBCC Voice of China | Dr. Kun Wang: The Role of Radiomics in Precision Assessment and Prediction of Neoadjuvant Therapy for Breast Cancer
The highly anticipated 19th St. Gallen Breast Cancer Conference (SGBCC) is taking place from March 12 to 15, 2025, in Vienna, Austria, a city renowned for its rich musical heritage. This year’s conference features a special session, “Voice of China,” where leading breast cancer experts from CSCO BC share insights into China’s clinical, basic, and…
-
SGBCC 2025丨Dr. Javier Cortés: The Dual-Edged Breakthrough in Early HER2-Positive Breast Cancer Treatment – Innovative Targeted Drug Development and Trial Design Reform
From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC 2025) was held in Vienna, the City of Music. Leading global experts in breast cancer gathered to discuss cutting-edge advancements and hotly debated topics in breast cancer diagnosis and treatment. At the conference, Dr. Javier Cortés, Head of the International Breast…
-
Trastuzumab and Pertuzumab from QILU PHARMACEUTICAL: A Promising and Reliable Therapeutic Option for Patients with HER2-Positive Breast Cancer
Oncology Frontier has distilled key insights from this symposium, offering a comprehensive and detailed overview of the latest advancements in the management of HER2-positive breast cancer. Advancing Neoadjuvant Therapy for…
-
SGBCC 2025丨Dr. Giuseppe Curigliano: Cure Outlook for Advanced Breast Cancer Patients — Innovative Therapies and Treatment Challenges
From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC 2025) was held in Vienna, the capital of music. Experts from around the world in the field of breast cancer gathered to discuss cutting-edge advancements and hotly debated topics in breast cancer diagnosis and treatment. Oncology Frontier invited Dr. Giuseppe Curigliano,…
-
JOH | FFAR1/FFAR4 Agonists Show Promise in MASH Treatment
The ICONA trial was a multicenter, randomized, double-blind, placebo-controlled Phase IIb study that enrolled 280 patients with MASH between the ages of 18 and 75. Participants were randomly assigned to…
Connecting Medical Expertise through Media
